Moo Yong Park1, Sandra M Herrmann2, Ahmed Saad2, Alfonso Eirin2, Hui Tang2, Amir Lerman3, Stephen C Textor2, Lilach O Lerman4. 1. Divisions of Nephrology and Hypertension and Department of Internal Medicine, Soonchunhyang University, College of Medicine, Bucheon, Korea. 2. Divisions of Nephrology and Hypertension and. 3. Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; and. 4. Divisions of Nephrology and Hypertension and Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; and lerman.lilach@mayo.edu.
Abstract
BACKGROUND AND OBJECTIVES: Occlusive renovascular disease and hypertension may progress to CKD. Circulating levels of several biomarkers, including fibroblast growth factor (FGF)-23, Klotho, and soluble urokinase plasminogen activator receptor (suPAR), are altered in patients with CKD, but their role in essential hypertension (EH) and renovascular hypertension (RVH) remains unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Levels of FGF-23, Klotho, suPAR, plasminogen activator inhibitor (PAI)-1, tissue factor, and tissue factor pathway inhibitor (TFI) were measured in the inferior vena cava and renal vein of hypertensive patients with atherosclerotic renal artery stenosis (n=12) or age-matched participants with EH (n=12) and relatively preserved renal function. Single-kidney blood flow was measured to calculate renal release of markers. For control, peripheral vein levels were measured in healthy volunteers (HVs; n=12). RESULTS: FGF-23 levels did not differ among the groups, whereas Klotho levels were lower in participants with RVH and EH than in HVs, and suPAR levels were elevated in patients with RVH compared with HVs and patients with EH (6.1±1.5 versus 4.4±1.9 and 3.2±1.2 ng/ml, P<0.05). PAI-1 levels were higher in patients with RVH than in patients with EH, but tissue factor and TFI levels were not statistically significantly different. After adjustment for GFR, Klotho levels remained decreased in both RVH and EH, and suPAR and PAI-1 levels remained elevated in RVH. eGFR correlated inversely with systemic and renal vein suPAR levels, and directly with systemic Klotho levels. CONCLUSIONS: Klotho levels are low in hypertensive patients, whereas suPAR and PAI-1 levels are specifically elevated in RVH, correlating with GFR. Klotho, PAI-1, and suPAR may be markers of kidney injury in hypertensive patients.
BACKGROUND AND OBJECTIVES:Occlusive renovascular disease and hypertension may progress to CKD. Circulating levels of several biomarkers, including fibroblast growth factor (FGF)-23, Klotho, and soluble urokinase plasminogen activator receptor (suPAR), are altered in patients with CKD, but their role in essential hypertension (EH) and renovascular hypertension (RVH) remains unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Levels of FGF-23, Klotho, suPAR, plasminogen activator inhibitor (PAI)-1, tissue factor, and tissue factor pathway inhibitor (TFI) were measured in the inferior vena cava and renal vein of hypertensivepatients with atherosclerotic renal artery stenosis (n=12) or age-matched participants with EH (n=12) and relatively preserved renal function. Single-kidney blood flow was measured to calculate renal release of markers. For control, peripheral vein levels were measured in healthy volunteers (HVs; n=12). RESULTS:FGF-23 levels did not differ among the groups, whereas Klotho levels were lower in participants with RVH and EH than in HVs, and suPAR levels were elevated in patients with RVH compared with HVs and patients with EH (6.1±1.5 versus 4.4±1.9 and 3.2±1.2 ng/ml, P<0.05). PAI-1 levels were higher in patients with RVH than in patients with EH, but tissue factor and TFI levels were not statistically significantly different. After adjustment for GFR, Klotho levels remained decreased in both RVH and EH, and suPAR and PAI-1 levels remained elevated in RVH. eGFR correlated inversely with systemic and renal vein suPAR levels, and directly with systemic Klotho levels. CONCLUSIONS:Klotho levels are low in hypertensivepatients, whereas suPAR and PAI-1 levels are specifically elevated in RVH, correlating with GFR. Klotho, PAI-1, and suPAR may be markers of kidney injury in hypertensivepatients.
Authors: Alfonso Eirin; Monika L Gloviczki; Hui Tang; Mario Gössl; Kyra L Jordan; John R Woollard; Amir Lerman; Joseph P Grande; Stephen C Textor; Lilach O Lerman Journal: Eur Heart J Date: 2012-07-06 Impact factor: 29.983
Authors: Hyoung Rae Kim; Bo Young Nam; Dong Wook Kim; Min Woong Kang; Jae-Hyun Han; Mi Jung Lee; Dong Ho Shin; Fa Mee Doh; Hyang Mo Koo; Kwang Il Ko; Chan Ho Kim; Hyung Jung Oh; Tae-Hyun Yoo; Shin-Wook Kang; Dae Suk Han; Seung Hyeok Han Journal: Am J Kidney Dis Date: 2013-03-27 Impact factor: 8.860
Authors: Ahmed Saad; Sandra M S Herrmann; John Crane; James F Glockner; Michael A McKusick; Sanjay Misra; Alfonso Eirin; Behzad Ebrahimi; Lilach O Lerman; Stephen C Textor Journal: Circ Cardiovasc Interv Date: 2013-07-30 Impact factor: 6.546
Authors: Ivana Pavik; Philippe Jaeger; Lena Ebner; Carsten A Wagner; Katja Petzold; Daniela Spichtig; Diane Poster; Rudolf P Wüthrich; Stefan Russmann; Andreas L Serra Journal: Nephrol Dial Transplant Date: 2012-11-04 Impact factor: 5.992
Authors: Changli Wei; Howard Trachtman; Jing Li; Chuanhui Dong; Aaron L Friedman; Jennifer J Gassman; June L McMahan; Milena Radeva; Karsten M Heil; Agnes Trautmann; Ali Anarat; Sevinc Emre; Gian M Ghiggeri; Fatih Ozaltin; Dieter Haffner; Debbie S Gipson; Frederick Kaskel; Dagmar-Christiane Fischer; Franz Schaefer; Jochen Reiser Journal: J Am Soc Nephrol Date: 2012-11-08 Impact factor: 10.121
Authors: Christopher J Cooper; Timothy P Murphy; Donald E Cutlip; Kenneth Jamerson; William Henrich; Diane M Reid; David J Cohen; Alan H Matsumoto; Michael Steffes; Michael R Jaff; Martin R Prince; Eldrin F Lewis; Katherine R Tuttle; Joseph I Shapiro; John H Rundback; Joseph M Massaro; Ralph B D'Agostino; Lance D Dworkin Journal: N Engl J Med Date: 2013-11-18 Impact factor: 91.245
Authors: Darcy K Weidemann; Alison G Abraham; Jennifer L Roem; Susan L Furth; Bradley A Warady Journal: Am J Kidney Dis Date: 2020-01-24 Impact factor: 8.860
Authors: Franz Schaefer; Howard Trachtman; Elke Wühl; Marietta Kirchner; Salim S Hayek; Ali Anarat; Ali Duzova; Sevgi Mir; Dusan Paripovic; Alev Yilmaz; Francesca Lugani; Klaus Arbeiter; Mieczyslaw Litwin; Jun Oh; Maria Chiara Matteucci; Jutta Gellermann; Simone Wygoda; Augustina Jankauskiene; Günter Klaus; Jiri Dusek; Sara Testa; Aleksandra Zurowska; Alberto Caldas Afonso; Melissa Tracy; Changli Wei; Sanja Sever; William Smoyer; Jochen Reiser Journal: JAMA Pediatr Date: 2017-11-06 Impact factor: 16.193
Authors: Maria Del Nogal-Avila; Hector Donoro-Blazquez; Manish K Saha; Caroline B Marshall; Lionel C Clement; Camille E A Macé; Sumant S Chugh Journal: Am J Physiol Renal Physiol Date: 2016-05-04